IP Library › Granted Patent US 9,113,270
Granted Patent B2
US 9,113,270 · App. 13/667,142 · Granted Aug 18, 2015

Transpositional acoustic frequency range in EAS patients

Inventor: Marek Polak (Innsbruck, AT)
Assignee: MED-EL Elektromedizinische Geraete GmbH
H04R25/353A61F11/04A61N1/0541A61N1/36032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,113,270
App. No.
13/667,142
Granted
Aug 18, 2015
Kind
B2
Abstract

An electric acoustic stimulation (EAS) hearing system includes a signal processor for processing an acoustic signal input to generate: i. an electrical communications signal representative of an upper electrical range of acoustic frequencies, and ii. an acoustic communications signal representative of a lower acoustic range of acoustic frequencies, the acoustic range including: (1) a lower subrange of acoustic frequencies perceivable by the patient with amplification, and (2) an upper subrange of acoustic frequencies not perceivable by the patient, wherein the signal processor uses frequency transposition to include the upper subrange in the lower subrange. An implanted electrical stimulation subsystem receives the electrical communications signal and delivers a corresponding electrical stimulation signal to auditory neural tissue of an implanted patient. An external acoustic stimulation subsystem receives the acoustic communications signal and delivers a corresponding amplified acoustic stimulation signal to the ear canal of the patient.

Claims (11)

1. A method for an electric acoustic stimulation (EAS) hearing system comprising:

processing an acoustic signal input to generate:

i. an electrical communications signal representative of an upper electrical stimulation range of acoustic frequencies characterized by a lowest electrical frequency limit corresponding to a lowest acoustic frequency perceivable by ab EAS system patient via electrical stimulation, and

ii. an acoustic communications signal representative of a lower acoustic stimulation range of acoustic frequencies, characterized by a highest acoustic frequency limit corresponding to a highest acoustic frequency perceivable by the patient via acoustic-mechanical stimulation

wherein the highest acoustic frequency limit and/or the lowest electrical frequency limit are selected to intentionally create a frequency gap of acoustic frequencies not perceivable by the patient, and

wherein the acoustic stimulation range contains acoustic information from the frequency gap based on frequency transposition;

receiving the electrical communications signal with an implanted electrical stimulation subsystem that delivers a corresponding electrical stimulation signal to auditory neural tissue of the patient; and

receiving the acoustic communications signal with an external acoustic stimulation subsystem that delivers a corresponding amplified acoustic-mechnical stimulation signal to the ear canal of the patient.

2. A method according to claim 1 , wherein the acoustic stimulation range contains acoustic information from a lower range frequencies in the frequency gap, and the electrical stimulation range includes acoustic information from an upper range of frequencies in the frequency gap.

3. A method according to claim 2 , wherein the acoustic information from the frequency gap is included in the electrical stimulation range by frequency transposition.

4. A method according to claim 2 , wherein the acoustic information from the frequency gap is included in the electrical stimulation range by frequency compression.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2013
From: POLAK, MAREK
To: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
Reel/Frame 029804/0835 →
Continuity (3)
Provisional Application 61555599 · Nov 4, 2011
Provisional Application 61557456 · Nov 9, 2011
Related Publication 20130116746A1 · May 9, 2013